Target intelligence / Profile preview

Mitochondrial reactive oxygen species–generating processes (mtROS generation)

Target
mtROS generation
Molecular classification
Enzyme, Mitochondrial respiratory chain, Oxidoreductase, Protein complex
01

Overview

Mitochondrial reactive oxygen species (mtROS)–generating processes encompass the biochemical pathways within the mitochondria, primarily the electron transport chain (ETC), that produce superoxide and other reactive oxygen species as byproducts of oxidative phosphorylation. The major sites of generation are Complex I (NADH:ubiquinone oxidoreductase) and Complex III (ubiquinol-cytochrome c reductase), where electron leakage to molecular oxygen occurs during electron transfer. While basal levels of mtROS serve as important signaling molecules for cellular adaptation, homeostasis, and immune response, excessive production leads to oxidative stress, damaging mitochondrial DNA, proteins, and lipids. This dysfunction is a hallmark of various pathologies, including neurodegenerative diseases like Parkinson's, cardiovascular disorders such as ischemia-reperfusion injury, and the biological process of aging. Therapeutic strategies include mitochondria-targeted antioxidants like MitoQ and site-specific suppressors of electron leak (S1QELs and S3QELs) that aim to reduce pathological ROS production without compromising the organelle's primary role in energy metabolism.

Other names
Mitochondrial ROS productionMitochondrial superoxide generationmtROS generationMitochondrial electron transport chain ROS productionMitochondrial oxidative stress generation
02

Mechanism of action

Scavenging of mitochondrial ROS, inhibition of specific electron leak sites (S1QELs/S3QELs), or modulation of electron transport chain complexes to reduce superoxide production.

03

Biological functions

Signal transductionApoptosisOxidative stressCellular metabolismRedox signalingHypoxic adaptation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationDiabetesAgingIschemia-reperfusion injury
05

Safety considerations

Potential for ATP depletion due to ETC inhibitionMitochondrial toxicityInterference with physiological ROS signaling (hormesis)Off-target effects on non-mitochondrial oxidoreductases
06

Interacting drugs

MitoQ

9 more in the full profile.

07

Biomarkers

MitoSOX (superoxide indicator)Mitochondrial membrane potential (ΔΨm)Malondialdehyde (MDA)8-hydroxy-2-deoxyguanosine (8-OHdG)Glutathione (GSH/GSSG ratio)

Beyond the preview

Go deeper on Mitochondrial reactive oxygen species–generating processes (mtROS generation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial reactive oxygen species–generating processes (mtROS generation).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call